Drug-receptor interactions electrostatic

Electrostatic forces are due to the ionic charges residing on the molecules, which attract or repel each other. The macromolecular structures of the receptors and enzymes mean that there are a number of ionic charges to attract the oppositely charged drug molecules. The forces of electrostatic interactions are weaker than covalent bonding. Electrostatic interactions are more common in drug-receptor interactions. There are two types of electrostatic interactions ... 

Thus, non-covalent hydrophobic interactions, hydrogen bonds, and electrostatic bonds all contribute to the overall shape of a protein (Figure 13.3). As we shall see (Section 13.3.2), many pertinent properties of a protein are then provided by the appropriate combination of the remaining amino acid side-chains that reside on the surface, allowing specific binding to various molecules. This is the essence of enzymic activity and drug-receptor interactions. 

As the electrostatic potential is of importance in the study of intermolecular interactions, it has received considerable attention during the past two decades (see, e.g., articles on the molecular potential of biomolecules in Politzer and Truhlar 1981). It plays a key role in the process of molecular recognition, including drug-receptor interactions, and is an important function in the evaluation of the lattice energy, not only of ionic crystals. 

Electrostatic bonding is much more common than covalent bonding in drug-receptor interactions. Electrostatic bonds vary from relatively strong linkages between permanently charged ionic molecules to weaker hydrogen bonds and very weak induced dipole interactions such as van der Waals forces and similar phenomena. Electrostatic bonds are weaker than covalent bonds. 

Drug-receptor interaction depends on optimal steric and electrostatic complementarity of their combining surfaces. Quantification of the binding... 

Apart from causing very well known cardiotoxic effects, phenothiazine derivatives can accumulate in lung epithelial cell membranes and therefore cause severe respiratory disorders. In the study performed by Ito et al. [279] it was found that CPZ (9) inhibited transepithelial Cl transport, mainly due to two mechanisms influence on the beta-adrenergic receptor and inhibition of basolateral potassium channels. The authors of this study also suggested that the recorded effects could result from the electrostatic interactions between the drug molecules and negatively charged components of the inner leaflet of the plasma membrane. 

According to the equation (21.2), ligand-receptor interactions are characterized by enthalpy-entropy compensation in which one term favors and the other disfavors binding. While enthalpic contributions include electrostatic, hydrogen bond, and Van der Waals interactions, entropic contributions arise from several sources. On one hand, the loss of flexibility upon binding has an important entropic cost, counterbalanced on the other hand by the displacement of ordered water molecules. This will be discussed in the next section as well as the various types of drug-receptor interactions. 

---